Local News: Osceola, AR 

 | 

Sign Up

 | 

Sign In

Advertisment

Cytosar-U, Cytarabine

Oct 8, 2009 | Posted by: roboblogger

Antisoma to Amend ACCEDE Phase III Study of AS1413 After Discussions With FDA

Full story: Pharmaceutical Processing

Antisoma has announced that, following discussions with FDA and trial investigators, it plans to amend the primary endpoint in the ACCEDE study of AS1413.

Leave a Comment

Comments

Type in your comments to post to the forum
Name
(appears on your post)
Comments
Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Cytosar-U, Cytarabine Discussions

Search the Cytosar-U, Cytarabine Forum:
Topic Updated Last By Comments
Bone cancer treatment ineffective, despite prom... (Nov '08) Nov '08 sid34 1
FDA Grants Full Approval for DepoCyt for the Tr... (Jun '07) Jun '07 mike wagner 1

Be the talk of the town

Get your topix hats, t-shirts & more!

Shop our store now!

Daily Horoscope for December 23

Virgo

Words are flying around in all directions today, and the conversations will be fast and furious. You might face a lot of distractions and interruptions, or you could get caught up in some rather irritable slanging matches with a certain person. The busier you are, the more fraught you'll become and the more likely to go off the deep end.

Get your Horoscope »